lilly tirzepatide lawsuit The weight-loss drug wars just got a courtroom subplot. Novo Nordisk — the OG of GLP-1s — is suing Eli Lilly, alleging its rival's ads misleadingly claim Zepbound beats Wegovy. The catch? Eli Lilly can proceed with

The incidence of severe hypoglycemia in patients with type 2 diabetes was 5% at 26 weeks in patients receiving TOUJEO as part of a multiple daily injection regimen, and 1.0% and 0.9% respectively at 26 weeks in the two studies where patients received TOUJEO as part of a basal-insulin only regimen

May be suitable for broader BMI ranges

A healthy diet, stress management, and a consultation with a fertility expert can all contribute to hormonal imbalance being corrected

Why vial size matters for your calculations Every reconstitution calculation starts with knowing exactly how much peptide you have

Spray tan is a thin mist that is sprayed onto skin and uses specialist equipment, so is usually done by a technician

Eli Lilly, the maker of the injectable weight loss drug Zepbound, is also currently working on a pill version